APGE

Apogee Therapeutics (APGE)

About Apogee Therapeutics (APGE)

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Details

Daily high
$80.99
Daily low
$77.30
Price at open
$77.77
52 Week High
$80.99
52 Week Low
$26.20
Market cap
4.7B
Dividend yield
0.00%
Volume
2.8M
Avg. volume
980,988
P/E ratio
-18.19

Apogee Therapeutics News

Details

Daily high
$80.99
Daily low
$77.30
Price at open
$77.77
52 Week High
$80.99
52 Week Low
$26.20
Market cap
4.7B
Dividend yield
0.00%
Volume
2.8M
Avg. volume
980,988
P/E ratio
-18.19